Serum AMH is now used as a diagnostic test in infertile women undergoing controlled ovarian stimulation as part of an in vitro fertilization (IVF) program (6) and in the assessment of polycystic ovarian syndrome (PCOS), risk of ovarian hyperstimulation syndrome, prediction of menopause and monitoring the impact of cytotoxic chemotherapy and radiotherapy on ovarian function. Here, AMH is linked to polycystic ovary syndrome.